Ares Genetics GmbH is part of the OpGen group. Together, we improve patient care and fight AMR through cutting edge molecular microbiology.
Ares Genetics is revolutionizing how we address the global challenge of AMR. Ares enables better infection control and more targeted patient care by providing unprecedented insight into AMR through NGS and AI powered solutions. Our innovative AI powered and machine learning (ML) driven approach leverages the extensive, curated database ARESdb to comprehensively detect and determine the genetic profile of pathogens.
Unlike conventional molecular assays, Ares Genetics solutions not only detect AMR markers but shed light on prevalence and diagnostic performance for these markers and predict how pathogens will respond to therapy.